News

Using CORRONA Registry Data to Treat Rheumatic Diseases


 

The Consortium of Rheumatology Researchers of North America (or CORRONA) primarily manages a database, and data analysis, of rheumatic diseases. Dr. Joel Kremer, CORRONA president and CEO, offered an update on the group's work at the 2012 Perspectives of Rheumatic Diseases in Newport Beach, Calif., held by Global Academy for Medical Education. GAME and this news organization are owned by Frontline Medical Communications.

Recommended Reading

Certolizumab Eased Skin and Joint Symptoms in PsA
MDedge Dermatology
Tocilizumab Beats Adalimumab in Monotherapy RA Trial
MDedge Dermatology
Psoriatic Arthritis Screening Tests Deemed Inadequate
MDedge Dermatology
Early Data Find No Adalimumab Teratogenicity
MDedge Dermatology
Methotrexate Cuts Anti-Adalimumab Antibody Production
MDedge Dermatology
Meta-Analysis Shows 75% Increased Risk Herpes Zoster With Anti-TNF
MDedge Dermatology
Subclinical Enthesitis Is More Common in Psoriatic Arthritis
MDedge Dermatology
Anti-TNF Use Linked to Cardiovascular-Disease Drop in RA
MDedge Dermatology
Biologic Agents for RA Don't Appear to Raise Malignancy Risk
MDedge Dermatology
Psoriasis Severity Linked to Tonsil Size
MDedge Dermatology